390 related articles for article (PubMed ID: 34830192)
1. Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet.
Takeishi J; Tatewaki Y; Nakase T; Takano Y; Tomita N; Yamamoto S; Mutoh T; Taki Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830192
[TBL] [Abstract][Full Text] [Related]
2. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.
Broom GM; Shaw IC; Rucklidge JJ
Nutrition; 2019 Apr; 60():118-121. PubMed ID: 30554068
[TBL] [Abstract][Full Text] [Related]
3. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
[TBL] [Abstract][Full Text] [Related]
4. Ketogenic Diet in Alzheimer's Disease.
Rusek M; Pluta R; Ułamek-Kozioł M; Czuczwar SJ
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405021
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
6. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
Hertz L; Chen Y; Waagepetersen HS
J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
[TBL] [Abstract][Full Text] [Related]
7. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
Kapogiannis D; Avgerinos KI
Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
Croteau E; Castellano CA; Richard MA; Fortier M; Nugent S; Lepage M; Duchesne S; Whittingstall K; Turcotte ÉE; Bocti C; Fülöp T; Cunnane SC
J Alzheimers Dis; 2018; 64(2):551-561. PubMed ID: 29914035
[TBL] [Abstract][Full Text] [Related]
9. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
[TBL] [Abstract][Full Text] [Related]
10. Are ketogenic diets promising for Alzheimer's disease? A translational review.
Lilamand M; Porte B; Cognat E; Hugon J; Mouton-Liger F; Paquet C
Alzheimers Res Ther; 2020 Apr; 12(1):42. PubMed ID: 32290868
[TBL] [Abstract][Full Text] [Related]
11. Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report.
Horner S; Berger L; Gibas K
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101777. PubMed ID: 32305654
[TBL] [Abstract][Full Text] [Related]
12. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
Chung JY; Kim HS; Song J
Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
[TBL] [Abstract][Full Text] [Related]
13. Intermittent fasting and Alzheimer's disease-Targeting ketone bodies as a potential strategy for brain energy rescue.
Ye YC; Chai SF; Li XR; Wu MN; Cai HY; Wang ZJ
Metab Brain Dis; 2024 Jan; 39(1):129-146. PubMed ID: 37823968
[TBL] [Abstract][Full Text] [Related]
14. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
[TBL] [Abstract][Full Text] [Related]
16. A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.
Beckett TL; Studzinski CM; Keller JN; Paul Murphy M; Niedowicz DM
Brain Res; 2013 Apr; 1505():61-7. PubMed ID: 23415649
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
Zhao WQ; Townsend M
Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
[TBL] [Abstract][Full Text] [Related]
18. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
[TBL] [Abstract][Full Text] [Related]
19. A Brief Review of Caprylidene (Axona) and Coconut Oil as Alternative Fuels in the Fight Against Alzheimer's Disease.
Chintapenta M; Spence J; Kwon HI; Blaszczyk AT
Consult Pharm; 2017 Dec; 32(12):748-751. PubMed ID: 29467067
[TBL] [Abstract][Full Text] [Related]
20. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
